Neurons are highly specialized cells that communicate with each other by electrical and chemical means at synapses. At chemical synapses, neurotransmittercontaining synaptic vesicles are rapidly emptied into the synaptic cleft in response to an influx of Ca 2+ ions through voltage-gated Ca 2+ channels, triggered by action potentials 1 (FIG. 1) . Maintaining electrochemical gradients and releasing and recycling synaptic vesicles are all highly energy-demanding processes. In addition, these processes are all regulated by Ca 2+ signalling. Thus, Ca 2+ levels must be tightly controlled in the presynaptic compartment, both spatially and temporally. Furthermore, to carry out the processing of information that is central to nervous system function, neurons must have a highly organized structure, with synapses positioned at various locations away from the cell body, where the nucleus resides. Thus, neurons need a mechanism whereby local energy usage can be spatially matched to energy production and to buffer Ca 2+ . Mitochondria are ideally suited to support this spatial variability in metabolic demand and Ca 2+ buffering because they generate ATP (via oxidative phosphorylation) and take up Ca 2+ into the mitochondrial matrix. Furthermore, neuronal mitochondria form a highly dynamic and adaptable network, with individual organelles having a wide range of sizes and shapes 2 . Indeed, live-cell imaging of mitochondria in vitro and in vivo has demonstrated that their spatial configuration, in terms of both position and morphology, continually changes over time 3 . Therefore, it is no surprise that mitochondria are actively recruited to, and maintained at, presynapses, but such recruitment and maintenance are not ubiquitously observed as not all neuronal presynapses are occupied by a mitochondrion [4] [5] [6] [7] [8] [9] . Therefore, what might be the functional impact of presynaptic mitochondria? The prevailing view is that they have two canonical roles: ATP provision and Ca 2+ buffering. However, this view prompts further questions. Are mitochondria required at synapses under basal conditions or only during increased activity? Are there other roles for mitochondria at the presynapse? How might these be compromised in disease?
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In this Review, we outline the mechanisms governing mitochondrial recruitment and their trafficking to and from presynapses and discuss their role in synaptic development and pruning. We then consider ATP provision and Ca 2+ buffering by mitochondria in the presynaptic compartment and in the context of synaptic transmission before highlighting other putative roles for these organelles, some of which depend on their canonical functions. We also discuss how presynaptic mitochondrial dysfunction could contribute to the pathogenesis of disease, focusing on neurodegenerative conditions as this area has attracted the most scrutiny. We conclude by highlighting future research directions, which will help illuminate some of the many unknowns in this field.
Trafficking to and from the presynapse During eukaryotic evolution, most mitochondrial proteins came to be encoded in the nuclear genome, leaving only a handful to be encoded by mitochondrial DNA. Although mitochondria can replicate their DNA locally in axons 10 , mitochondrial biogenesis mainly takes place near the nucleus 11 . These organelles are then actively trafficked to where they are needed in the cell. This ability to transport mitochondria is particularly important in cells with complex and variable morphology such as neurons.
In cultured hippocampal neurons, 10-20% of axonal mitochondria are motile, and their transport occurs at velocities ranging from 0.2 to 2 μm per s (REFS 6, 12) . In the mammalian periphery, electrical stimulation increases the proportion of mitochondria that are motile and mitochondrial velocity, with anterograde movement specifically enhanced as stimulation is ramped up 13 . With maturation, the proportion of motile mitochondria substantially decreases in cortical neurons in vitro 14 and in the cortex and retina in vivo 8, 14, 15 , and as mitochondria become less mobile, they spend more time at presynaptic boutons 8, 14, 15 . This decline in motility is paralleled by increased expression of syntaphilin (an axonal mitochondrial docking protein) with neuronal age 16 . The long-distance movement of mitochondria from the soma to presynapses (anterograde movement) and back (retrograde movement) is largely conducted via the microtubule network and a set of motor proteins (FIG. 2a) . Anterograde movement is mediated by kinesin motors, whereas retrograde movement is mainly mediated by dynein motors. Trafficking kinesin-binding proteins (TRAKs) are also required for mitochondrial motility and interact with kinesin heavy chain isoform 5 (KIF5) and dynein 17, 18 . Mitochondrial motility is tightly regulated by the mitochondrial Rho GTPases (MIROs). MIRO1 and MIRO2 feature two GTPase domains that flank two EF-hand, Ca 2+ -sensing domains and a carboxy-terminal domain localizing the protein to the outer mitochondrial membrane. Miro, the Drosophila melanogaster orthologue of the mammalian MIROs, is required for anterograde transport to synapses 19, 20 , as well as for dynein-driven transport into dendrites, and this movement is dependent on its amino-terminal GTPase domain 21 . Thus, MIRO proteins provide a potential interface by which mitochondria interact with a range of molecular motors and their regulating partners.
MIRO1 coordinates mitochondrial trafficking by sensing Ca 2+ via its EF-hand domains, which enables mitochondria to stop at areas of increased intracellular [Ca 2+ ] ([Ca 2+ ] i ). Precisely how MIRO1 achieves this is not completely understood. One possible explanation is that the increasing [Ca 2+ ] i inhibits an interaction between MIRO1 and KIF5, releasing mitochondria from trafficking machinery 22 (FIG. 2b) . Alternatively, a study in mammalian cells and D. melanogaster showed that Miro can interact with KIF5 via milton (the fly signals to power and to regulate synaptic transmission, respectively. Ca 2+ influx triggers fusion of synaptic vesicles in the readily releasable pool (RRP) with the plasma membrane at the active zone, emptying their contents of neurotransmitter (in this example, glutamate) into the synaptic cleft. In turn, the neurotransmitter acts on postsynaptic receptors to effect synaptic transmission. Synaptic vesicles are then endocytosed and return to the recycling pool (RP) for use on future occasions. AMPAR (FIG. 2c) . However, recent studies in Miro1-knockout mice showed that mitochondrial movement could still be inhibited by increasing the [Ca 2+ ] i 24 , and although axonal trafficking of mitochondria was markedly slowed in Miro1-knockout hippocampal neurons, the spatial distribution of mitochondria was unchanged in axons 25 . These findings suggest that MIRO2 is sufficient for mitochondrial stopping. A third possibility is that, upon binding to Ca 2+ , MIRO1 detaches from KIF5, which can then bind syntaphilin, anchoring mitochondria to microtubules 12 (FIG. 2d) . MIRO1 also enhances mitochondrial Ca 2+ uptake via the mitochondrial calcium uniporter (MCU), and the resulting increase in matrix [Ca 2+ ] can itself act as a signal to slow mitochondrial trafficking 26 .
MIROs and TRAKs can also interact with mitofusins, which regulate mitochondrial fusion 27 . MIRO1 overexpression increases mitochondrial length in neurons 28 , an alteration that is further enhanced by over expressing EF-hand domain mutants (suggesting that the basal [Ca 2+ ] i inhibits mitochondrial fusion) and that can be reproduced by overexpression of a constitutively active GTPase form of MIRO1 (REFS 28, 29) . Thus, MIROs are capable of coordinating mitochondrial fusion-fission with trafficking.
MIRO function is a prerequisite for neuronal health: Miro1 knockout in mice is lethal in the early postnatal period 24, 25 . Moreover, conditional knockout of this gene leads to degeneration of corticospinal neurons and certain cranial nerve nuclei 24 ; these neurons show impaired retrograde mitochondrial transport but unaffected mitochondrial ATP generation and Ca 2+ buffering. Similarly, conditional knockout of Miro1 preferentially depletes dendritic mitochondria, compromising neuronal survival 25 . These reports highlight that perturbation of mitochondrial trafficking alone can lead to neuronal loss.
Glucose can also regulate mitochondrial position. TRAKs can form a complex with O-linked N-acetylglucosamine (O-GlcNAc) transferase 110 kDa subunit (OGT), the activity of which depends on glucose availability. In fly and rodent neurons, the O-GlcNAcylated state of milton and TRAK1, respectively, is increased by extracellular glucose and, although the precise mechanism is not yet understood, this post-translational alteration of a key mitochondrial adaptor protein is capable of leading to mitochondrial arrest 30 . Furthermore, surface glucose transporter levels increase in the presynaptic compartment during synaptic activity and action-potential firing, thereby increasing local glucose uptake 31, 32 . Therefore, mitochondria can be positioned at locations of increased glucose availability, which may help optimize ATP delivery via oxidative phosphorylation.
These signals act cooperatively to position mitochondria at presynapses. Once there, mitochondria may undergo functional and structural specialization: synaptic mitochondria are morphologically different from mitochondria elsewhere, being smaller and having increased motility 5 and a higher ratio of cristae to outer membrane surface area, which is consistent with a higher metabolic demand 33 . Synaptic mitochondria also have a distinct metabolic profile: they are more sensitive to complex I inhibition 34 and Ca 2+ overload than nonsynaptic mitochondria 35 , possibly owing to their relative isolation, older age and accumulated exposure to oxidative damage, which renders them susceptible to elimination
.
Synapse development and pruning
For neuronal circuits to function properly, neuronal connections need to be established and appropriately remodelled in response to changing demands. Local protein synthesis is increasingly recognized to play a critical role in the development and remodelling of synapses 36 , and mitochondria are prime candidates for Nature Reviews | Neuroscience supplying the energy to fuel these processes. Indeed, axonal branching of chick dorsal root ganglia in response to exogenous nerve growth factor occurs at sites with stalled mitochondria, mediated by the phosphatidylinositol 3-kinase (PI3K) pathway 37 . Given the developmental coupling between presynaptic specialization and axon branching and stabilization 38, 39 , it is conceivable that mitochondria could also fuel the maturation of presynapses. Indeed, branching in mouse cortical axons is mediated by liver kinase B1 (LKB1; also known as STK11) and NUAK family SNF1-like kinase 1 (NUAK1), and these kinases are necessary and sufficient to immobilize mitochondria at nascent presynaptic sites 40 . It is not yet established how these captured mitochondria drive axonal branching, but ATP provision seems to be the likely mechanism: mitochondria provide the ATP that is essential for assembly of the presynaptic specialization at the Xenopus laevis neuromuscular junction (NMJ), and inhibition of ATP synthase here blocks the clustering of synaptic vesicles and local F-actin assembly that are induced by growth factors 41 . The anti-apoptotic factor BCL-X L (B cell lymphoma-extra large has been shown to drive presynaptic maturation via increasing the GTPase activity of dynamin-related protein 1 (DRP1; also known as DNM1L), a key regulator of mitochondrial fission 42 , thereby enhancing presynaptic mitochondrial recruitment 43 . The targeted elimination of synapses is a crucial step in the maturation of neuronal circuits as the surfeit of synapses formed during development is reduced in number to those required [44] [45] [46] . Neuronal activity is a key driver of this process [47] [48] [49] [50] and, unsurprisingly, mitochondria are involved in mediating it 51 . Mitochondrial activation of caspase 3 plays a role in the pruning of postsynaptic spines 52 , and a recent study has showed that caspase 3 may also have a role in the elimination of presynaptic structures. Triggering of the apoptotic cell death pathway by axonal mitochondria promotes the selective elimination of presynaptic structures in Caenorhabditis elegans during development via F-actin disassembly 53 , which is mediated by Ca 2+ -regulated gelsolin proteins. This pathway was discovered through an unbiased genetic screen revealing that cell death protein 3 (CED3; the worm homologue of human caspase 3) loss of function led to major defects in the localization of presynaptic components.
Provision of ATP
Glycolysis is capable of liberating cellular energy directly from the breakdown of glucose, and certain neuronal functions exhibit a preference for this method of fuel generation. For example, fast axonal transport of vesicles relies on glycolysis, and vesicles are furnished with their own set of glycolytic enzymes 54 . However, during development, neurons (from rodents at least) use ketone bodies as their primary fuel source 55 , which require mitochondria for their metabolism and the subsequent liberation of ATP 56 . Furthermore, induced pluripotent stem cells switch from glycolysis to oxidative phosphorylation as they differentiate into neurons 57 . Overall, mitochondria generate more than 90% of cellular ATP, powering the majority of functions within the cell, and oxidative phosphorylation is the main mechanism providing energy for neuronal activity 58, 59 . Presynaptic processes (including Ca 2+ clearance, transmitter uptake and synaptic vesicle recycling and refilling) are all energy demanding 60 (FIG. 3) , but how can these highly dynamic demands be met?
Mitochondrial position impacts synaptic transmission.
An early clue came from pharmacological inhibition of oxidative phosphorylation, which compromised synaptic neurotransmission during long-term stimulation 61 . These findings were substantiated by genetic studies in D. melanogaster. Ablation of Miro in flies depleted presynapses of mitochondria, leading to synaptic depression after long-term activity 19 . Similarly, mutations in Drp1 impaired synaptic transmission 62 . Notably, defects in mitochondrial localization were seen in Drp1-knockout flies: most synapses in these flies contained far fewer mitochondria than did synapses in controls and failed to maintain neurotransmission when they were stimulated at high frequency
Box 1 | Elimination of damaged mitochondria
Damaged mitochondria produce excess reactive oxygen species that are harmful to the cell and therefore need to be eliminated. Under normal conditions, mitochondrial serine/threonine-protein kinase PINK1 (PINK1; also known as PTEN-induced putative kinase protein 1) is imported into mitochondria, where it is cleaved and then digested in the proteasome. However, depolarized mitochondria fail to import PINK1, which instead accumulates on the outer mitochondrial membrane (OMM) (see figure, part a). PINK1 then phosphorylates ubiquitin (p-ubiquitin in the figure), which can be bound by parkin, facilitating parkin phosphorylation by PINK1 (see the figure, parts b,c). This phosphorylation activates parkin's E3 ubiquitin ligase activity, enabling parkin to further ubiquitylate OMM proteins (see the figure, part d). This ubiquitylation triggers the autophagic machinery to engulf and digest damaged mitochondria in a process called mitophagy (reviewed in REF. 195 ).
The PINK1-parkin pathway has also been implicated in mediating the pruning of oxidized cargo proteins from mitochondria in the form of mitochondria-derived vesicles (MDVs), which are targeted to lysosomes 196 . An apparently separate population of MDVs is targeted to peroxisomes 197 , although it is not clear at present why different MDVs are degraded via different pathways. Nevertheless, MDVs enable mitochondria to maintain the integrity of the mitochondrial network without having to eliminate entire organelles in response to damage.
Parkin-independent mitophagy pathways have also been identified, such as the recently described peptidyl-prolyl cis-trans isomerase FKBP8-microtubuleassociated protein 1 light chain 3α (LC3A) pathway 198 . The FUN14 domaincontaining protein 1 (FUNDC1) pathway is another parkin-independent mitophagy pathway and is activated in hypoxic conditions 199 or upon exposure to acute mitochondrial toxins 200 . Intriguingly, some cells can remove damaged mitochondria by shedding them extracellularly: mouse retinal ganglion cell axons appear to shed the majority of their damaged mitochondria at the optic nerve head, which are then internalized and degraded by neighbouring astrocytes 201 . This phenomenon is yet to be described in other cell subtypes, but it highlights that mitophagy is not exclusively cell autonomous. ψ, membrane potential. Nature Reviews | Neuroscience Readily releasable pool (RRP). The pool of synaptic vesicles that are available for immediate release, being docked at the presynaptic active zone and primed for release.
owing to a specific defect in mobilizing reserve pool vesicles to replenish the readily releasable pool (RRP). The deficit in neurotransmission could be partially rescued by the local application of ATP, and the knockout phenotype could be recapitulated with drugs that block mitochondrial ATP production but not Ca 2+ buffering. ATP is required for myosin ATPase to power vesicle mobilization 63 and is converted to GTP to activate dynamin-mediated synaptic vesicle endocytosis 64 . These studies provide a mechanistic explanation for why ATP is important for replenishment of the RRP of vesicles.
Mice lacking Drp1 develop abnormally 65 and die after embryonic day 12.5. Cultured neurons from these mice have fewer neurites and exhibit abnormal synapse formation, possibly because mitochondria fail to distribute properly within developing neurons. Indeed, DRP1-dependent mitochondrial fission appears to be dispensable for nonpolarized cells but is crucial for extremely polarized cells such as neurons 66 .
Drp1 ablation in adult mouse neurons has been shown to impair synaptic transmission 67, 68 . One of these studies also showed that Drp1 loss markedly increases the size of, and distance between, mitochondria within mouse hippocampal axons 67 . Under basal activity, ATP levels (determined by ATP fluorescence resonance energy transfer (FRET) sensors) were normal in the soma and synapses in these Drp1-knockout neurons. By contrast, synaptic ATP levels could not be maintained following repetitive stimulation, whereas ATP levels in the soma were unchanged. However, available ATP sensors have limited sensitivity, making such comparisons challenging.
Mitochondrial motility affects prolonged activity.
Syntabulin is a KIF5B adaptor protein that attaches to mitochondria to mediate anterograde movement along axons 69 . A study showed that small interfering RNA (siRNA) suppression of syntabulin in superior cervical ganglion neurons reduced mitochondrial distribution in axons and dendrites and caused synaptic dysfunction, comprising reduced basal activity, impaired transmission at high frequency, slower recovery after synaptic vesicle depletion and impaired short-term plasticity 70 . The provision of ATP could partially rescue transmission under intense stimulation; however, it could not rescue the deficit in basal transmission (the authors speculated that this deficit in basal transmission may be due to impairments in the transport of other presynaptic components). ATP was also needed for vesicle recruitment into the RRP. A different study showed that de novo ATP synthesis is required to maintain ATP levels during stimulation and, although glycolysis is required for maintaining basal ATP levels, both glycolysis and oxidative phosphorylation boost ATP during increased activity 71 . These studies point to a role for mitochondrial ATP in sustaining long-term synaptic transmission.
Recent work highlights the importance of glycolysis in powering active synapses. In C. elegans, glycolytic enzymes localize to active synapses under conditions of energy stress 72 , and in rodent neurons, active synapses recruit glucose transporter type 4 (GLUT4; also known as SLC2A4) to the presynaptic plasma membrane to provide additional fuel for glycolysis 32 . It is worth noting that these mechanisms could also enable increased ATP provision from local mitochondria because glycolysis operates upstream of oxidative phosphorylation by supplying pyruvate.
Balancing synaptic efficiency and information transfer. Theoretical modelling suggests that maximizing the probability of release paradoxically reduces the amount of information that is conveyed in the spike train 73 . Therefore, there may be a computational advantage in having variable synaptic transmission efficiency. Explanations for this variability have placed considerable emphasis on ion channels, synaptic vesicle kinetics and receptor concentration at synapses, but these factors cannot account for the dynamics of pulse-to-pulse variability (PPV) at single boutons that are responding to identical stimuli. Perhaps mitochondria can account for this variability? Presynaptic mitochondria maintain vesicle release and the ATP/ADP ratio when neurons are repetitively stimulated 74 . Increasing the proportion of motile mitochondria, by knocking out the mitochondrial anchor protein syntaphilin, elevated PPV, whereas syntaphilin overexpression reduced mitochondrial motility and lowered PPV 74 . The application of oligomycin, which blocks ATP synthesis, made mitochondriacontaining boutons behave similarly to those without mitochondria, whereas basal and evoked Ca 2+ transients were equivalent in boutons with and without mitochondria 74 , suggesting that altered levels of ATP, but not of Ca 2+ , contribute to synaptic variability. However, are nearby mitochondria necessary for local ATP provision? One study reported that mitochondrially derived ATP rapidly dispersed in axons, such that presynapses with and without mitochondria had an equivalent capacity for vesicle cycling 75 . By contrast, other studies have shown that ATP exhibits limited cytoplasmic diffusion 76, 77 . The aforementioned study determined boutons solely on morphology; therefore, it is possible that not all of the boutons were detected in this investigation. Interestingly, when the authors compared boutons with and without mitochondria in the same axon, lower levels of ATP were measured in mitochondria-free boutons 75 . In agreement, the ATP/ADP ratio decreases more in boutons without mitochondria than in boutons with mitochondria after repeated stimulation, even when glucose is present 74 . Although glycolysis or ATP diffusion from distant mitochondria may be sufficient for basal activity, a consistent picture emerges of presynaptic mitochondria being utilized to match the higher energy demands of prolonged, repetitive or intense stimulation. Mitochondrial ATP provision may also influence the efficiency of synaptic transmission 74 . This view is supported by an ultrastructural study of the rat hippocampus, which found a larger decrease in the number of synaptic vesicles in presynaptic boutons containing mitochondria than in those without after long-term potentiation (LTP) induced by theta burst stimulation 9 . However, the correlation between the presence of presynaptic mitochondria and synaptic vesicle depletion in this study was not as strong in adult rats compared with postnatal day 15 (P15) animals, possibly because, at P15, synapses are more reliant on mitochondria to metabolize ketone bodies. As we discuss next, mitochondrial Ca 2+ handling may in fact be a more important regulator of synaptic vesicle release.
Regulation of Ca
2+ signalling Ca 2+ plays a central role mediating intracellular signalling over diverse timescales and distances to fulfil many functions. Presynaptically, a very brief Ca 2+ spike (generated by an action potential) triggers emptying of neurotransmitter-containing vesicles into the active zone (FIG. 4) ] i >2.5 μM). However, it is unclear whether presynaptic mitochondrial occupancy was determined in this study, potentially underestimating the contribution of mitochondria to Ca 2+ clearance. The same caveat applies to a study that found no difference in the probability of release at hippocampal neuronal synapses with and without mitochondria 86 : here, the mitochondrial position was not imaged concurrently with vesicle release, and presynaptically and postsynaptically located mitochondria could not be distinguished. 96 . However, presynaptic mitochondrial occupancy was not determined in this study. Thus, any mitochondrial contribution to Ca 2+ buffering would be underestimated, given that many presynapses are devoid of mitochondria.
Retinal bipolar neurons.
Recently, we and others reported that presynaptic mitochondria actively attenuate presynaptic Ca 2+ transients in response to trains of action potentials, thereby downregulating synaptic vesicle release in hippocampal 97 and cortical neurons 98 . These effects were ablated by blocking MCUs. One of the studies identified LKB1 as a regulator of MCU abundance and showed that MCU expression could rescue synaptic transmission defects in Lkb1-null neurons (comprising reduced presynaptic Ca 2+ buffering, increased asynchronous release and impaired short-term plasticity) 98 . We showed that mitochondria are differentially recruited to the presynapse during homeostatic plasticity, with enhanced recruitment when network activity is upregulated and reduced recruitment when network activity is inhibited 97 . This recruitment is dependent on the Ca 2+ -sensing EF-hand domains of MIRO1 and on the buffering of Ca 2+ by MCUs. This finding is consistent with previous work demonstrating that MCU-mediated Ca 2+ uptake is required for LTP in a mouse model of hyperalgesia 99 . Thus, mitochondrial positioning can contribute to synaptic rescaling over long timescales. We observed a threshold effect whereby mitochondria influenced Ca 2+ transients only in response to trains of 20 or more action potentials 97 . This phenomenon might be associated with complete depletion of the RRP of synaptic vesicles (which are thought to be fully released within 40 action potentials 100 ) and might relate to a requirement for a high local [Ca 2+ ] i to trigger Ca 2+ uptake via MCUs.
An active regulator of synaptic transmission. Clearly, mitochondria are important players in presynaptic Ca 2+ regulation. These studies highlight the importance of taking neuronal type, preparation temperature and mitochondrial position (relative to the presynapse) into account when determining mitochondrial impact on presynaptic function. Far from a passive Ca 2+ sink operating remote from the presynapse, they are actively recruited to this compartment to tune synaptic activity over time. Thus, the picture becomes complex: although mitochondria are utilized to support increased activity in synapses, they can also downregulate synaptic function over a longer timescale.
How does mitochondrial Ca 2+ regulation fit with provision of ATP? The two might be linked, as an increase in the former has been shown to stimulate production of the latter in mouse neuronal cultures 101 and cardiac myocytes 102 . It is not understood how this happens, but it may involve increases in [Ca 2+ ] i mediating the activation of citric acid cycle and oxidative phosphorylation enzymes 103 . Overall, presynaptic mitochondria are recruited to sites of Ca 2+ flux and are utilized to support prolonged activity via ATP provision; however, they simultaneously place an upper limit on synaptic activity levels via Ca 2+ uptake. This provides a powerful homeostatic mechanism: prolonged synaptic activity is linked to appropriate provision of energy substrates; however, excess activity is tempered by the buffering of Ca 2+ , and the processes are managed by the same organelle. Therefore, why might some synapses be devoid of mitochondria? Mitochondrial motility increases synaptic variability by altering ATP homeostasis 74 , and recruitment of mitochondria to and from presynaptic boutons allows neurons to rescale synapses in response to long-term changes in network activity 97 . Thus, not being dependent upon locally positioned mitochondria could furnish neurons with greater computational flexibility.
Mitochondria and the ER
Mitochondria are associated with the ER at contact regions called mitochondria-associated ER membranes (MAMs), which comprise 5-20% of the mitochondrial surface. Just as mitochondria form a network that is distributed throughout the neuron, so too does the ER, and it is increasingly recognized that mitochondria-ER interactions can modulate a wide range of physiological processes, including ATP synthesis, autophagy, mitochondrial trafficking and apoptosis (reviewed in REF. 104 ).
Perhaps most pertinent for presynaptic function, the ER also buffers Ca 2+ and can thus help shape Ca 2+ signalling via interacting with mitochondria. A recent electron microscopy study in mouse brain tissue has revealed that the ER forms a web surrounding mitochondria and other organelles at presynapses 105 . dysfunction in yeast triggers the nuclear transcription of genes that supply mitochondria with substrates to help compensate for a failing citric acid cycle. In mammalian cells, altered Ca 2+ signalling has been implicated as an additional mechanism by which mitochondria can report back to the cell. A specific neuronal impact has been reported in D. melanogaster: inducing mitochondrial damage depleted presynapses of mitochondria and reduced neuronal viability 112 . This effect could be rescued, without salvaging mitochondria, by blocking retrograde signalling mediated by sima (the fly homologue of hypoxia-inducible factor 1α (HIF1α)).
Mitochondrial reactive oxygen species (ROS) exert cellular damage but can also regulate the strength of postsynaptic GABA type A (GABA A ) receptors at the inhibitory synapses of stellate cells 113 . Thus, cellular metabolism can be coupled to the strength of synaptic transmission. ROS can impinge on signalling pathways by oxidizing key moieties on proteins to alter their activity or function. Mitochondrial ROS are now recognized to be important in hypoxia adaptation, autophagy, immunity, differentiation and longevity (reviewed in
REF. 114).
Mitochondria can also integrate and respond to other signals that can impact presynaptic function, including IGF1 signalling as outlined above 93 . Brainderived neurotrophic factor has also been shown to increase mitochondrial docking at presynaptic sites, in a MIRO1-dependent manner, by increasing intracellular Ca 2+ levels via PI3K and phospholipase Cγ pathways 115 . Intriguingly, neuronal mitochondrial membranes have been shown to contain cannabinoid receptor 1 (CNR1; also known as CB1; a G-protein-coupled receptor). Activation of these receptors leads to inhibition of presynaptic mitochondrial respiration, which contributes to regulation of hippocampal short-term plasticity 116 , and their knockout prevents memory impairment induced by cannabinoids 117 , providing a further link between presynaptic mitochondrial bioenergetics and neuronal function.
Biosynthesis of macromolecules
Mitochondria play a critical role in the biosynthesis of various important molecules, including lipids, hormones and neurotransmitter intermediates 118, 119 . This biosynthetic role is implicated in D. melanogaster NMJ development 120 : flies expressing a mutant form of the transmembrane GTPase Marf (required for correct mitochondrial fusion) had fewer presynaptic mitochondria and exhibited morphologically abnormal NMJs. The mutant NMJs also failed to maintain synaptic transmission during repetitive stimulation (although basal transmission is unaffected). The production of steroid hormones in ring glands (a major insect endocrine organ) was affected in the mutant flies and thought to be the cause of the NMJ pathology (ablating Marf solely in neurons did not lead to NMJ pathology, whereas loss of Marf in ring glands did). The phenotype was fully reversed by expressing human mitofusin 1 (MFN1) and MFN2, pointing to a conserved mechanism. MFN2 in particular has been implicated in human steroid hormone synthesis, suggesting that disordered mitochondrial hormone production also affects mammalian synapses. Of note, aromatase (which synthesizes oestradiol and is located in the ER) is expressed in synapses, raising the possibility of synaptocrine signalling (reviewed in REF. 121 ). Indeed, mutations in optic atrophy protein 1 (OPA1), which cause optic atrophy, have been shown to dysregulate mitochondrial steroid production in the retina, promoting apoptosis of retinal ganglion cells 122 . Mitochondria are also crucial contributors to the synthesis of haem -the key component of haemoglobin and cytochromes, which regulate many signalling processes within the brain. Haem deficiency leads to neuronal senescence 123 and neurite degeneration that is mediated by NMDA receptor-dependent extra cellular signal-regulated kinase 1 (ERK1) and ERK2 activation 124 , highlighting an important synaptic role for this molecule.
Frataxin is a mitochondrial protein involved in ironsulfur complex biosynthesis, the dysfunction of which leads to defective mitochondrial transport to synapses and reduced mitochondrial membrane potential in D. melanogaster 125 . By the late third instar stage, NMJs of affected flies accumulate an excess of depolarized mitochondria.
Role in disease pathogenesis
We have discussed the importance of presynaptic mitochondria to synaptic, and indeed neuronal, homeo stasis. How might their dysfunction contribute to disease? Genetic links between mitochondria and disease are well established: mutations in many genes that encode proteins critical to mitochondrial function give rise to multisystem hereditary diseases known collectively as the mitochondrial cytopathies. Furthermore, impaired mitochondrial fusion resulting from mutations in OPA1 causes optic atrophy 122 , and impairments from mutations in MFN2 can cause Charcot-Marie-Tooth disease type 2A (a familial neuropathy) 120 . Defective haem biosynthesis can lead to porphyria, which is deleterious to neuronal function 126 . Mutations in FXN (which encodes frataxin) lead to Friedreich's ataxia, with involvement of sensory neurons in the spinal cord 125 . However, what about presynaptic mitochondria specifically? Recent work showed that mitochondrial uncoupling protein 2 (UCP2) is required for correct synaptic remodelling in response to hypoxia, which is considered important in perinatal hypoxia, epilepsy and stroke 127 . Furthermore, neurons are postmitotic and, apart from a few exceptions, are not replenished in adulthood 128 ; therefore, they are vulnerable to premature attrition in neurodegenerative diseases, including Alzheimer disease (AD), Parkinson disease (PD) and amyotrophic lateral sclerosis (ALS) (FIG. 5) . Synaptic degeneration may precede neurodegeneration. For example, a mouse model of hereditary spastic paraplegia (featuring degeneration of corticospinal axons) due to recessive mutations in the SPG7 gene (encoding the mitochondrial ATPase paraplegin) exhibited morphological abnormalities in synaptic terminals and distal axons,
Wallerian degeneration
The degeneration of an axon distal to the site of an injury.
which preceded degeneration but coincided with motor impairment 129 . Synapses might also degenerate early in the course of AD 130 and PD 131 . Affected neurons may then die back, akin to Wallerian degeneration. Here, we discuss and speculate on the available evidence that presynaptic mitochondria might play a key pathogenic role in these conditions. Alzheimer disease. AD is the most common cause of dementia and features the degeneration of cortical neurons and certain subcortical structures. The pathology of the disease includes the accumulation of extracellular plaques of the peptide amyloid-β (Aβ) and the formation of intracellular tangles of tau 132 , although precisely why neurons are lost in this disease is not fully understood.
Studies in rodent cortical synaptosomes have shown that mitochondrial dysfunction can be triggered by exposure to Aβ [133] [134] [135] . Furthermore, acute Aβ exposure impaired mitochondrial transport in hippocampal axons 136, 137 . By contrast, chronic exposure to mild mitochondrial stress has been shown to increase retrograde mitochondrial transport by releasing syntaphilin anchor proteins before activating parkin-mediated mitophagy 138 . Moreover, syntaphilin release has been seen in neurons from mouse models of AD and ALS and in brain tissue from individuals with AD 138 . Separate work has identified an increase in retrograde transport of damaged mitochondria to the soma in neurons from mouse models of AD and in brain tissue from humans with AD 139 . Once mitochondria are presynaptically located, AD pathology may alter the fission-fusion of mitochondria, with deleterious consequences. Nitric oxide, produced in response to exposure to Aβ oligomers, triggered mitochondrial fission, synaptic loss and neurodegeneration in rodent cortical neurons, partly via S-nitrosylation of Nature Reviews | Neuroscience . The brains of those with AD feature upregulated insulin-like growth factor 1 receptor (IGF1R) signalling, which increases mitochondrial Ca 2+ uptake and ATP release, impacting synaptic transmission 93 . Mitochondrial fission is also affected: oligomeric Aβ upregulates dynamin-related protein 1 (DRP1) via nitric oxide (NO) signalling 140 , whereas downstream tau pathology attenuates DRP1 activity by increasing its propensity to remain actin bound 143 . Phosphorylated tau also inhibits anterograde mitochondrial movement 145 . b | Parkinson disease (PD) features misfolding and aggregation of α-synuclein, a protein that is localized to MAMs (binding to vesicle-associated membrane protein-associated protein B/C (VAPB)) but relocates under pathological conditions, impairing MAM function 183 . α-Synuclein overexpression inhibits complex I and depolarizes mitochondria, leading to their fragmentation 177 . α-Synuclein overexpression inhibits synaptic vesicle release 181 . Mitochondrial serine/threonine-protein kinase PINK1 (PINK1) deficiency can also impair neurotransmitter release by inhibiting complex I, thereby reducing mitochondrial energy production 173 . Dysfunctional mitochondrial quality control in PD is highlighted by disease-causing mutations in PINK1 (REF. 159) and PARK2 (REF. 160 ), which encodes parkin, both of which are required for appropriate tagging of mitochondria for mitophagy. ψ, membrane potential; GRP75, 75 kDa glucose-regulated protein (also known as HSPA9); IGF1, insulin-like growth factor; IP3, inositol trisphosphate; MCU, mitochondrial calcium uniporter; MIRO, mitochondrial Rho GTPase; Pi, inorganic phosphate; RP, reserve pool; VDAC, voltage-dependent anion-selective channel protein.
DRP1, and this modification of DRP1 was also detected at higher levels in brain tissue from individuals with AD than in that from controls 140 . DRP1 can also directly interact with Aβ 141 , and depletion of DRP1 reduces mitochondrial dysfunction and improves synaptic activity in a mouse model of AD 142 . Interestingly, disease-associated mutant tau appears to inhibit DRP1 activity by preventing its interaction with mitochondria (via actin stabilization), leading to impaired fission, elongated and dysfunctional mitochondria and inappropriate cell cycle re-entry, leading to cell death 143 . Lowering DRP1 levels can improve mitochondrial and synaptic function in a mouse model of tauopathy 144 . Furthermore, phosphorylated tau disrupted mitochondrial transport in mouse cortical neurons 145 , and in D. melanogaster, RNAi knockdown of milton or Miro exacerbated human tau-induced neurodegeneration and tau phosphorylation at the AD-related site Ser262 (REF. 146 ), highlighting the synergy between defective trafficking machinery and phosphorylated tau. Tau depletion can ameliorate deficits in neuronal activity and behaviour in transgenic mouse models of AD 147, 148 by preventing Aβ-induced defects in axonal transport 149 , emphasizing that axonal transport is critically important for maintaining neuronal viability.
Aβ is transported into mitochondria via the translocase of the outer membrane (TOM) complex and associates with the mitochondrial inner membrane 150 . Cyclophilin D (CYPD; also known as PPID), a key component of MPTPs, has been shown to interact with mitochondrial Aβ and to potentiate synaptic dysfunction, whereas cortical neurons deficient in CYPD were more resistant to Aβ-induced mitochondrial dysfunction and MPTP opening, and CYPD depletion alleviated synaptic dysfunction, as well as learning and memory deficits, in an AD mouse model 151 . A study in D. melanogaster has provided support for these key findings: overexpression of human Aβ leads to intracellular accumulation of Aβ, slowed axonal mitochondrial transport, depleted presynaptic mitochondria and synaptic vesicles and depressed synaptic transmission 152 . The overexpression of the ' Arctic' form of Aβ, a mutation found in a Swedish family with AD, accelerated the manifestation of these effects 152 . Altered Ca 2+ handling by presynaptic mitochondria at the mossy fibre synapse has been observed as an early deficit in AD mouse models overexpressing a mutant form of human amyloid precursor protein (APP), from which Aβ is derived, or featuring knockout of presenilin 1 (PSEN1), which is required for normal processing of APP into Aβ 153, 154 . Increased IGF1 signalling has been found in brain tissue from people with AD 155 and in the hippocampi of transgenic mice overexpressing both mutant APP and PSEN1 (REF. 156 ). In an AD mouse model, blockade of IGF1 signalling corrected early presynaptic dysfunction (comprising increased basal transmission, but reduced short-term plasticity, and preceding synaptic loss and the development of Aβ plaques) mediated by altered mitochondrial Ca 2+ handling and ATP generation 93 . AD pathology can also alter how mitochondria and the ER interact at MAMs. Upregulated MAMassociated proteins have been observed in brain tissue from individuals with AD and from the APP Swe/Lon mouse model (which harbours disease-causing mutations in APP), and this was an early pathological event because it preceded the development of amyloid plaques 157 . Nanomolar concentrations of oligomeric Aβ elevated expression of components of a mitochondrial-ER bridging complex (namely, VDAC and the inositol trisphosphate receptor), increased the number of mitochondrial-ER contact points, augmented ER-to-mitochondrial Ca 2+ transfer and thus increased mitochondrial [Ca 2+ ] in neuroblastoma cells. Furthermore, siRNA-mediated knockdown of one or the other of two putative MAM-associated proteins (phosphofurin acidic cluster sorting protein 2 or the sigma non-opioid intracellular receptor 1) triggered degeneration of mouse hippocampal neurons, highlighting the importance of MAMs for neuronal survival.
Parkinson disease. PD is the most common neurodegenerative movement disorder, featuring a loss of midbrain dopaminergic neurons, which causes the clinical triad of tremor, rigidity and bradykinesia (slowness of movement). Mitochondria were first implicated in PD when complex I deficiency was observed in PD brain tissue 158 . The identification of mutations in PINK1 (encoding mitochondrial serine/threonineprotein kinase PINK1) 159 and PARK2 (also known as PRKN; which encodes parkin) 160 as causative of autosomal recessive forms of familial PD underlined the importance of mitochondria in maintaining midbrain dopaminergic neurons. The PINK1-parkin pathway is central to mitophagy
. In most cells, this occurs close to the soma where lysosomes are abundant. In neurons, this can be achieved by increasing movement of damaged mitochondria back towards the soma 161 where parkin-targeted mitochondria accumulate 162 . In vivo studies in D. melanogaster support the view that neuronal mitophagy resides largely in the soma 163, 164 . Indeed, anterograde axonal transport of mitochondria is reduced in mouse dopaminergic neurons deficient in respiratory chain enzymes 165 or exposed to the neurotoxin 1-methyl-4-phenylpyridinium (MPP+), which also increases retrograde transport 166 . In vivo imaging in zebrafish has also revealed substantially increased retrograde movement of mitochondria in dopaminergic neurons exposed to MPP+ (REF. 167 ). These findings highlight the importance of appropriate trafficking of mitochondria in response to neuronal stress.
However, damaged mitochondria can also cease movement via PINK1-parkin-mediated degradation of MIRO1 (REF. 168 ). MIRO1 turnover on damaged mitochondria is altered in fibroblasts from individuals with PD bearing PARK2 mutations 169 . Recently, leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2), another PD-related protein, has been shown to bind MIRO1, aiding its degradation, whereas pathogenic mutations in LRRK2 impair such binding, delaying the arrest and subsequent removal of damaged mitochondria 170 .
Therefore, specific disruption of mitochondrial transportation (via MIRO1-induced mitochondrial arrest) may be pathogenic in PD. Such stationary mitochondria have been shown to be capable of locally recruiting parkin, autophagosomes and lysosomes to achieve mitophagy in situ 171 . If this pathway is faulty, damaged mitochondria could accumulate in axons and presynapses in PD. It will be important to determine whether such local mitophagy is capable of clearing damaged mitochondria at presynapses and how this relates to disease.
Impairments in dopamine release and synaptic plasticity have also been observed in Pink1-knockout mice 172 . The cause of these impairments may be related to impaired mitochondrial energy production, as PINK1 deficiency compromises complex I function, and in PINK1-deficient flies, reserve pool vesicles fail to mobilize during rapid stimulation, which can be corrected with exogenous ATP 173 . SNCA (encoding α-synuclein) was the first gene to be linked to familial PD 174 , and α-synuclein is the principal protein component of Lewy bodies -a pathological hallmark of the disorder 175 . α-Synuclein is important in PD pathogenesis (whether sporadic or familial), but precisely how remains poorly understood. Indirect clues suggest that α-synuclein induces presynaptic mitochondrial dysfunction. α-Synuclein is predominantly cytosolic, but it mislocalizes to mitochondria during cellular stress 176 . In a hypothalamic neuronal tumour cell line, α-synuclein overexpression induces complex I inhibition and mitochondrial membrane depolarization 177 . Transgenic mice expressing mutant α-synuclein show neurodegeneration with altered mitochondrial morphology and mitochondrial DNA damage 178 and trafficking 179 . In parallel, α-synuclein accumulates presynaptically during neurodegeneration 180 . Furthermore, transgenic α-synuclein overexpression impairs neurotransmitter release 181 and enlarges synaptic vesiclesa phenotype also observed in animal models lacking key synaptic proteins 182 . The intracellular localization of α-synuclein has been refined to reveal its presence in MAMs 183 . Mutant α-synuclein alters this localization and reduces mitochondrial-ER apposition, decreases MAM function and increases mitochondrial fragmentation 183 . Recently, α-synuclein has been shown to bind to vesicleassociated membrane protein-associated protein B/C (VAPB) 184 . VAPB is an ER protein for which the amino terminus projects into the cytosol and interacts with an outer mitochondrial membrane protein -namely, protein tyrosine phosphatase-interacting protein 51 (PTPIP51; also known as RMDN3) 185 . Thus, VAPB is a MAM protein and can alter how mitochondria take up Ca 2+ when it is released from ER stores. Mutant α-synuclein disrupts VAPB-PTPIP51 tethering, thereby loosening mitochondria-ER interactions 184 . Recently, the absence of PARK2 has been shown to increase ER and mitochondrial apposition and to increase ER-to-mitochondria Ca 2+ transfer in mice, fibroblasts from patients and patient-derived neurons 186 , and an overabundance of MFN2 was implicated in mediating these effects.
A role for HIF1α has also been implicated in PD. Knockdown of sima restored function in a D. melanogaster model of parkin PD 112 , suggesting that HIF1α signalling is an interesting therapeutic target to explore.
Amyotrophic lateral sclerosis. ALS is a neurodegenerative disorder that specifically affects upper and lower motor neurons. Mutations in Cu/Zn superoxide dismutase 1 (SOD1) cause a familial form of ALS 187 . The pathogenic role of SOD1 mutations is not understood; however, motor neurons from mice expressing human mutant SOD1 exhibit impairment of (especially anterograde) mitochondrial axonal transport 188 . In this study, the mitochondria exhibited a rounder morphology and reduced membrane potential -both indicators of damage. Recently, mutant SOD1 has been reported to induce parkin-dependent degradation of MIRO1, which might explain the mitochondrial trafficking defect 189 . This finding also corroborates findings in Miro1-knockout mice, which feature upper motor neuron degeneration 24 . A wide range of D. melanogaster models of genetic ALS, owing to mutations in TARDBP (which encodes TAR DNA-binding protein 43 ((TDP43)), FUS (encoding RNA-binding protein FUS) or C9ORF72 (encoding chromosome 9 open reading frame 72), exhibit impaired axonal transport 190 , as do rodent neurons expressing ALS-causing mutant variants of VAPB 191 . These mutations in VAPB alter the encoded protein's ability to bind to PTPIP51 and increase mitochondrial Ca 2+ uptake. Expression of wild-type TDP43, or mutant forms of TDP43 associated with familial forms of ALS, has been shown to perturb mitochondrial-ER interactions by disrupting the relationship between VAPB and PTPIP51 (REF. 192 ). Accumulation of hyperphosphorylated, ubiquitylated and cleaved TDP43 is a feature common to ALS and a subset of frontotemporal dementia cases 193 , and mutations in TARDBP cause some sporadic and familial cases of ALS 194 . Whether or not the pathological processes described here in ALS also occur at the presynapse remains to be determined, but we predict that this will be a core feature of degenerating neurons, given the emerging importance of mitochondrial-ER interactions to presynaptic homeostasis outlined above. BOX 2 highlights therapeutic strategies that could be explored experimentally to enhance neuronal survival via boosting presynaptic mitochondrial function.
Conclusions
Of the many factors governing synaptic, neuronal and network activity, mitochondrial location and function have a major impact. However, if presynaptic mitochondria are so important, why are some presynapses devoid of them? Their absence may provide neurons greater computational flexibility, but this reason is not the full story. The role of mitochondria in signalling and biosynthesis as well as their interactions with the ER suggest that other factors must influence presynaptic mitochondrial occupancy. Furthermore, the regulation of trafficking of mitochondria to and from presynapses and the full extent of mitochondrial function once there remain incompletely understood. Consequently, their contribution to disease pathogenesis is not yet fully defined.
The impact of mitochondria on the regulation of presynaptic function highlights the need to target these organelles more specifically. The use of genetically encoded reporters of mitochondrial position, [Ca 2+ ] i and synaptic vesicle release enables interactions between mitochondria and presynaptic function to be interrogated in real time and in vivo. This approach, combined with use of transgenic and induced pluripotent stem cell models of disease, should help us to understand how mutations that cause neurological disease can disrupt mitochondrial, synaptic and, consequently, neuronal homeostasis.
Box 2 | Therapeutic strategies targeting presynaptic mitochondria
The pharmacological modulation of mitochondrial function is a potentially powerful way of treating a wide variety of conditions that feature mitochondrial dysfunction. General enhancement of mitochondrial biogenesis and oxidative capacity can be achieved with resveratrol, which stimulates sirtuin 1 activity (mimicking calorie restriction, which increases lifespan in a variety of organisms 202 ). Resveratrol has shown promise in a recent small clinical trial in Alzheimer disease (AD), attenuating the decline in cognition and reducing cerebrospinal fluid markers of inflammation 203 . MitoQ is a mitochondrially targeted form of coenzyme Q10 (a key part of the mitochondrial electron transport chain and an antioxidant) that has been shown to have beneficial effects in animal models of neurodegeneration, with attenuation of neuropathology and synaptic deficits in transgenic mouse models of AD 204, 205 and Huntington disease 206 . However, thus far this has not translated into demonstrable clinical improvement, at least in Parkinson disease 207 . Altering the balance of mitochondrial fission-fusion might also be therapeutically exploited. For example, genetic depletion of Drp1 reduces mitochondrial dysfunction and improves synaptic function in a mouse model of AD 142 . Mitochondrial division inhibitor 1 (MDIVI1), which has been widely considered to be an inhibitor of dynamin-related protein 1 (DRP1), offsets PINK1-induced mitochondrial dysfunction 208 and ameliorates mitochondrial dysfunction, synaptic depression and cognitive deficits in a mouse model of AD 209 . However, MDIVI1 was recently also shown to be a complex I inhibitor 210 . Promoting fission, with M1 hydrazone for example 211 , might be a viable alternative to MDIVI1. More specific modulation of mitochondria might prove beneficial, although this remains on the distant horizon. For example, enhancing mitochondrial trafficking in axons (via depletion of syntaphilin) increases regeneration following axonal crush injury by replenishing healthy mitochondria where they are needed 16 . A further option would be to upregulate armadillo repeat-containing X-linked protein 1 (ARMCX1), which has recently been implicated in mobilizing mitochondria to enhance axon regeneration following axotomy 212 .
Modulating precisely how mitochondria buffer Ca 2+ also has great potential and is critical to neuronal function. Loss of function of mitochondrial calcium uptake protein 1 (MICU1) leads to chronic activation of the mitochondrial calcium uniporter and causes a genetic disorder comprising muscle weakness, learning difficulties and progressive extrapyramidal motor dysfunction 213 .
Although not yet definitively demonstrated, it is speculated that synaptic defects in individuals with this disorder might account for some of the clinical phenotype 214 . Other mechanisms that regulate mitochondrial [Ca 2+ ] also have potential as therapeutic targets: the mitochondrial Na + /Ca 2+ exchanger is one such mechanism and recently has been shown to be essential for life 215 . A central challenge to these strategies is the specific targeting of neuronal mitochondria. Novel methods to guide drugs to neurons across the blood-brain barrier are in development 216 . These will likely prove pivotal in limiting the potential adverse effects of modulating mitochondrial activity in untargeted tissues, although any effects on non-neuronal cells in the brain must be kept in mind.
